Chiron launches HIV vaccine trial
January 17 2004 1:00 AM ET
Biotechnology company Chiron announced the launch Thursday of human clinical trials of its two-part experimental HIV vaccine, the Los Angeles Times reports. Participants in the trials will first receive a DNA-based vaccine containing two key HIV proteins to prime the immune system into recognizing the invading virus and a booster shot aimed at further stimulating an immune response. An initial two-year safety trial will involve 168 HIV-negative volunteers in St. Louis, Seattle, and Nashville. Additional efficacy tests will be conducted after the safety study.
- #TBT: They Died in the Closet
- Gallery of Geek: Yannick Tallarida
- Dan Savage Calls Out Duggar's 'Staggering' Family Values Hypocrisy
- Eurovision Winner Who Called Gays an 'Abnormality' Changes Tune
- Op-ed: I'm a Trans Man Who Doesn't 'Pass' — And You Shouldn't Either
- Op-Ed: Gay Purple Heart Recipient Says 'Mission Not Accomplished'